Evidence map›Paper›PMID 38026637›Full record

ArticleFrontiers in veterinary science2023

Cathepsin W, T-cell receptor-associated transmembrane adapter 1, lymphotactin and killer cell lectin like receptor K1 are sensitive and specific RNA biomarkers of canine epitheliotropic lymphoma.

Jadesola Temitope Olayinka, Akanksha Nagarkar, Diana Junyue Ma, Neil B Wong, Andrew Romasco, Cesar Piedra-Mora, Linda Wrijil, Clement N David, Heather L Gardner, Nicholas A Robinson and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in veterinary science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Jadesola Temitope Olayinka *Department of Dermatology, UMass Chan Medical School, Worcester, MA, United States.
Akanksha NagarkarDepartment of Dermatology, UMass Chan Medical School, Worcester, MA, United States.
Diana Junyue MaDepartment of Dermatology, UMass Chan Medical School, Worcester, MA, United States.
Neil B WongDepartment of Dermatology, UMass Chan Medical School, Worcester, MA, United States.
Andrew RomascoDepartment of Dermatology, UMass Chan Medical School, Worcester, MA, United States.
Cesar Piedra-MoraPathology Department, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, United States.
Linda WrijilPathology Department, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, United States.
Clement N DavidNanostring Technologies, Seattle, WA, United States.
Heather L GardnerDepartment of Clinical Sciences, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, United States.
Nicholas A Robinson *Pathology Department, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, United States.
Kelly L HughesDepartment of Microbiology, Immunology and Pathology, Colorado State University Veterinary Diagnostic Laboratory, Fort Collins, CO, United States.
Bruce BartonDepartment of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States.
Cheryl A LondonDepartment of Clinical Sciences, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, United States.
Ramón M AlmelaDepartment of Clinical Sciences, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, United States.
Jillian M RichmondDepartment of Dermatology, UMass Chan Medical School, Worcester, MA, United States.
New England Disabled Sports · USUniversity of Massachusetts Chan Medical School · USColorado State University · USNanostring Technologies (United States) · USSUNY Downstate Health Sciences University · US

Funding

Elucidating the therapeutic utility of targeting metabolic dependencies in osteosarcomaK01OD028268 · OD · TUFTS UNIVERSITY BOSTON · PI GARDNER, HEATHER LYNN · 2020 to 2024
$631k
NIH HHS K01 OD028268
6 · The paper itself

Abstract

Cutaneous T-cell lymphoma (CTCL) is an uncommon type of lymphoma involving malignant skin-resident or skin-homing T cells. Canine epitheliotropic lymphoma (EL) is the most common form of CTCL in dogs, and it also spontaneously arises from T lymphocytes in the mucosa and skin. Clinically, it can be difficult to distinguish early-stage CTCLs apart from other forms of benign interface dermatitis (ID) in both dogs and people. Our objective was to identify novel biomarkers that can distinguish EL from other forms of ID, and perform comparative transcriptomics of human CTCL and canine EL. Here, we present a retrospective gene expression study that employed archival tissue from biorepositories. We analyzed a discovery cohort of 6 canines and a validation cohort of 8 canines with EL which occurred spontaneously in client-owned companion dogs. We performed comparative targeted transcriptomics studies using NanoString to assess 160 genes from lesional skin biopsies from the discovery cohort and 800 genes from the validation cohort to identify any significant differences that may reflect oncogenesis and immunopathogenesis. We further sought to determine if gene expression in EL and CTCL are conserved across humans and canines by comparing our data to previously published human datasets. Similar chemokine profiles were observed in dog EL and human CTCL, and analyses were performed to validate potential biomarkers and drivers of disease. In dogs, we found enrichment of T cell gene signatures, with upregulation of

Indexed as

cathepsin W (CTSW)cutaneous T cell lymphoma (CTCL)dog (canine)epitheliotropic lymphoma (EL)interface dermatitis (ID)killer cell lectin like receptor K1 (KLRK1)lymphotactin/XCL1/XCL2T cell receptor associated transmembrane adaptor 1 (TRAT1)

Identifiers

PMID38026637
PMCPMC10654980
OpenAlexW4388297379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.